龙大美食此番换将发生在极为敏感的时期。根据龙大美食此前披露的2025年度业绩预告，预计归母净利润亏损6.2亿元至7.6亿元，亏损幅度急剧扩大。对 此，龙大美食解释称，受行业周期影响，毛猪销售价格及猪肉市场价格持续低位运行，传统业务板块出现较大亏损，同时公司对存货及生物资产计提了减值 准备。 在发布巨亏业绩预告、因信披违规被监管处罚后不到一个月，龙大美食火速进行了高层人事调整。 日前，龙大美食发布公告称，因工作调整，身兼董事长与总经理的杨晓初辞去总经理职务，但仍担任董事长，"85后"刘婧正式接棒，出任新一任总经理。 对于刘婧而言，摆在面前的任务并不轻松。一方面需要应对业绩持续下滑的经营压力，另一方面更要着手处理公司内部治理与财务规范的历史遗留问题。在 财报屡屡"踩雷"之后，如何重建投资者信任，成为这位新任女总经理必须跨过的第一道坎。 除了业绩压力，合规层面的问题也在集中爆发。今年1月30日，山东证监局对龙大美食采取行政监管措施，发现2021年至2024年公司可转换公司债券相关募 投项目结转固定资产后未停止利息资本化，并将用于临时补充流动资金的募集资金利息资本化，导致相关定期报告信息披露不准确。 为此，龙大美食对 ...

记者丨李山 编辑丨彭康一 2026年开年至今，A股市场的退市节奏明显加快。东方退（300379）、*ST长药（300391）、*ST奥维 （002231）、*ST立方（300344）、广道数字（400295）五家公司皆因财务造假、信披违规被监管处 罚。 退市不是终点，监管部门正在打破"一退了之"的旧有格局，针对上述公司的违规追责与民事索赔才刚刚 开始。符合索赔条件的投资者可关注"投资快报"公众号，通过右侧"股民索赔"菜单栏挽回损失。 东方退：财务造假与欺诈发行 作为2026年首批退市公司之一，东方退的陨落极具代表性。1月22日，该公司正式从深交所摘牌，结束 了其在资本市场的旅程。 东方退的退市源于其长达四年的系统性造假。监管部门查明，在2019年至2022年期间，东方退通过全资 子公司虚构业务、提前确认收入等方式，累计虚增收入4.32亿元、虚增利润3.14亿元。 更严重的是，公司在2022年向特定对象发行股票时，《募集说明书》引用了这些虚假财务数据，构成了 欺诈发行，当时募集资金高达约22亿元。 两类投资者可参与索赔：（1）2019年3月30日—2024年4月29日期间买入，并在2024年4月30日之后卖出 ...

业绩层面之外，公司还因重大合同进展披露不及时，以及2022年年报和2023年半年度报告存在虚假记 载，导致股票被实施ST，公司及高管合计被处以千万元罚款。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源：证券之星 近日，ST东尼（维权）（东尼电子，603595.SH）发布公告称，公司拟转让其控股子公司东尼新能源合 计31.698%股权，以迅速回笼资金和优化资产结构。 证券之星注意到，受半导体业务销售额大幅下滑、亏损扩大的影响，公司去年归母净利润同比由盈转 亏。而东尼新能源作为公司的核心盈利主体，正处于业绩增长阶段，ST东尼却选择将其出表，此举令 人费解。 01． 丧失盈利子公司控制权 公告显示，ST东尼拟以2.3亿元的价格将其持有的东尼新能源21.698%股权转让给湖州东利和湖州人才基 金二期；10%股权转让给东尼新能源核心管理团队新设的员工持股平台用以股权激励，交易对价为 3335.67万元。 本次评估基准日为2025年11月30日，东尼新能源股东全部权益评估值为10.6 亿元，较净资产账面价值增 值7.26亿元，增值率达217.78%。交易同时设置业绩承诺：ST东尼实控人等 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 一、实控人自救引发监管关注 在2026年2月14日，*ST立方（维权）收到了《行政处罚正式决定书》，同日发布了《关于收到终止上 市事先告知书的公告》。 其实在此之前公司实控人采取了一系列行动，争取公司走向不退市的结局，但这些行动也引起了监管机 构的关注和质疑。 在 2025年11月29日，公司收到了《行政处罚事先告知书》，后在2026年1月18日实控人通过数媒发布了 《致立方数科全体股东的公开信》，信中强调公司经营一切正常，已提交详尽申辩材料并进行多轮沟 通，听证会两次延期，且《事先告知书》并非最终处罚决定。 然而，这一系列操作迅速引发监管层关注。就在公开信发布同日，公司董事会发出澄清公告，明确表示 公司及全体董事对上述信息不知情、未参与，相关内容并非经由法定信披渠道发布。 不过，在2026年1月20日复牌后当日涨停，并连续多个交易日大幅上涨。市场普遍 ...

Group 1 - The core issue is that Nanjing Pharmaceutical is under investigation by the China Securities Regulatory Commission for violations in annual report disclosures, highlighting significant flaws in the company's financial compliance [1][4] - The company has faced repeated accounting errors, including improper handling of sales returns and insufficient conditions for revenue recognition, leading to restatements of financial data [1][4] - The investigation represents a critical examination of the company's integrity and governance, emphasizing the importance for affected investors to protect their rights within the legal framework [1][4] Group 2 - Nanjing Pharmaceutical has announced a projected annual revenue of 120 million to 150 million yuan for 2025, a decline of approximately 43% to 54% compared to the previous year's revenue of 263 million yuan [2][4] - The company anticipates a net loss of 120 million to 160 million yuan, although this represents a reduction from the previous year's loss of 357 million yuan, indicating ongoing challenges in achieving profitability [2][4] - Factors contributing to the performance decline include intensified competition in the pharmaceutical industry and reduced demand for core products due to a decrease in flu cases, alongside a cautious approach to asset and credit impairment losses [2][5]

Group 1 - The core issue revolves around a recent court ruling where investors won a lawsuit against Wantong Development for false statements, indicating a significant precedent for similar cases [1][3] - The first ruling has established a legal basis for investors to pursue claims, potentially expediting the process for those who have not yet filed [3][4] - Investors who purchased shares between February 8, 2023, and February 17, 2023, and sold or still hold them after February 18, 2023, are eligible to participate in the compensation claims [3][4] Group 2 - The case originated from a disclosure violation in February 2023, where 5.17% of the company's shares held by major shareholders were judicially frozen but not disclosed in a timely manner [2][3] - During the period of delayed disclosure, Wantong Holdings reduced its stake by 1 million shares through block trading, which was a significant event that should have been disclosed [2][3] - The failure to disclose this information has been identified as a key basis for investor claims, as it directly impacted stock prices and investor decision-making [2][4]

Core Viewpoint - The rapid transition of Rongbai Technology from a highly praised company to one facing regulatory penalties highlights the risks associated with misleading disclosures in the capital market, particularly in the context of a significant contract announcement with CATL that was later deemed misleading by regulators [3][4][6][10]. Group 1: Contract Announcement and Regulatory Response - On January 13, Rongbai Technology announced a major contract with CATL for the supply of 3.05 million tons of lithium iron phosphate cathode materials over six years, with a projected value exceeding 120 billion yuan [7][24]. - The announcement was initially met with enthusiasm from the market, being interpreted as the largest order in the lithium iron phosphate sector [9][26]. - However, within 20 days, the China Securities Regulatory Commission (CSRC) issued a notice of administrative penalties, identifying the announcement as containing misleading statements, resulting in a fine of 4.5 million yuan for the company and additional fines for its chairman and secretary [4][10][27]. Group 2: Misleading Information and Internal Control Failures - The CSRC found multiple misleading elements in the announcement, including the inflated contract value, non-binding supply quantities, and undisclosed performance conditions set by CATL [9][26][32]. - The internal control mechanisms of Rongbai Technology were deemed ineffective, with key executives failing to perform due diligence on the announcement, leading to significant errors and omissions [15][34]. - The incident reflects a broader issue within cyclical industries, where management may prioritize short-term market performance over compliance and transparency [15][36]. Group 3: Financial Performance and Market Context - Rongbai Technology has faced significant operational challenges, with revenue and profit declining sharply over the past two years, leading to a projected loss of nearly 200 million yuan for the year [11][31]. - The company's effective production capacity for lithium iron phosphate was only 60,000 tons per year, which is insufficient to meet the projected demand of over 500,000 tons annually, indicating a substantial capacity gap [11][31]. - The attempt to leverage a high-profile contract to boost market confidence was ultimately counterproductive, as the market values actual performance and delivery capabilities over mere announcements [14][31]. Group 4: Future Challenges and Rebuilding Trust - The penalties imposed on Rongbai Technology serve as a reminder of the importance of accurate and transparent information disclosure in mature capital markets [19][37]. - Moving forward, the company must address its operational challenges, including how to achieve profitability in a saturated market and effectively implement its production plans [37]. - Rebuilding trust with investors and stakeholders will require a commitment to compliance, transparency, and a robust internal control framework [37].

Core Viewpoint - *ST Guandian is facing potential delisting risks due to negative financial performance, including projected losses for 2025 and insufficient operating revenue [2][3]. Financial Performance - The company expects a total profit of approximately -189 million yuan for 2025, with a net profit attributable to the parent company of around -185 million yuan [3]. - The operating revenue, after excluding unrelated business income, is projected to be about 123 million yuan, which is below the 100 million yuan threshold that could trigger financial delisting standards [3]. - Historical revenue figures show a decline from 291 million yuan in 2022 to 89.98 million yuan in 2024, with year-on-year changes of 26.61%, -27.12%, and -57.58% respectively [5]. - The net profit attributable to the parent company has also seen a significant drop, from 82.33 million yuan in 2022 to -136 million yuan in 2024, with year-on-year changes of 13.89%, -74.31%, and -744.26% respectively [5]. Corporate Governance - The company is currently led by Chairman Gao Yingxuan and Secretary Li Xuming, with a total of 195 employees [4]. - The actual controller of the company is Gao Ming [4]. Legal Issues - *ST Guandian is facing claims from investors due to disclosure issues, with affected investors eligible for compensation if they held shares during the specified period [3]. - The company has been flagged for potential violations of securities laws, which could lead to further legal repercussions [3]. Risk Indicators - The company has 45 internal risk indicators, with 29 warning alerts currently active [6].

Core Viewpoint - The company, Wento Holdings, is facing legal actions due to violations of information disclosure regulations, leading to investor claims for compensation following significant financial penalties and undisclosed legal matters [1][2][3][4] Group 1: Legal Proceedings - A lawsuit has been filed against Wento Holdings for securities false statements, with the opportunity for investors to join the case as the statute of limitations has not yet expired [1][3] - The China Securities Regulatory Commission (CSRC) issued a notice of investigation to Wento Holdings on May 9, 2024, for suspected violations of information disclosure laws [3] - On October 19, 2024, Wento Holdings received an administrative penalty decision from the Liaoning regulatory bureau, prompting investor compensation claims [1][3] Group 2: Violations of Information Disclosure - Wento Holdings failed to disclose significant compensation liabilities related to a development project agreement signed with the Nanjing Liuhe District People's Government, resulting in a forfeiture of 79.6532 million yuan as a penalty for non-compliance [2][4] - Between March 24, 2022, and February 23, 2023, Wento Holdings did not disclose 28 lawsuits and arbitration cases totaling 314 million yuan, which accounted for 14.82% of the latest audited net assets [2][4] - From March 2023 to August 10, 2023, the company faced an additional 29 undisclosed legal matters amounting to 244 million yuan [2][4] Group 3: Investor Compensation - Investors who purchased shares between January 8, 2021, and May 9, 2024, and sold or still hold shares after May 10, 2024, while incurring losses, are eligible to participate in the compensation claims [2][4]

Core Viewpoint - Hosheng Silicon Industry's investment of over 10 billion yuan has been concealed, potentially exposing governance issues within the company. The company recently received a regulatory letter and is now facing a share reduction plan from its controlling shareholder. Notably, the company has over 35 billion yuan in construction projects on its books, with significant discrepancies between actual investment and budgeted amounts, as well as slow project progress and no impairment recorded [1][2][4][5]. Group 1: Regulatory Issues - Hosheng Silicon Industry received two decision letters from the Zhejiang Securities Regulatory Bureau on January 16, indicating violations of information disclosure regulations. One letter mandated corrective measures for the company, while the other issued warnings to four key executives [2][5]. - The company failed to disclose over 1.6 billion yuan in related party transactions, which were not subjected to the required review procedures. These transactions included approximately 772 million yuan with Kaifa Joint Trading Co. and 2.45 billion yuan with Kuqa Juyou Coal Industry Co. from 2022 to 2024 [3][17]. Group 2: Investment Concealment - In October 2022, Hosheng Silicon's subsidiary signed a strategic cooperation framework agreement with the government of Hangzhou Xiaoshan District, with an initial investment of about 7 billion yuan, later increased to approximately 11 billion yuan in June 2023. These amounts represent 34.55% and 45.88% of the company's latest audited net assets, respectively [4][17]. - The company did not fulfill the necessary review and disclosure obligations regarding this substantial investment [4][18]. Group 3: Financial Performance - Hosheng Silicon reported a loss in the third quarter of 2025, with total revenue of 15.206 billion yuan, a year-on-year decrease of 25.35%. The net profit attributable to shareholders was -321 million yuan, a decline of 122.1% [19]. - The company indicated that the losses were primarily due to falling sales prices of industrial silicon, operational losses in the photovoltaic sector, and provisions for inventory depreciation [19]. Group 4: Construction Projects - The company has over 35 billion yuan in construction projects, with significant characteristics: first, the actual investment has exceeded budgeted amounts, and second, the progress of related projects appears to be slow. For instance, the coal-electricity-silicon integration project has seen cumulative investments surpassing 120% of its budgeted amount [8][10][24]. - Despite the slow progress of these projects, the company has not recorded any impairment on these assets [13][25].